Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ibd/izaa202 http://scihub22266oqcxt.onion/10.1093/ibd/izaa202 32793973!7454666!32793973     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32793973&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Inflamm+Bowel+Dis 2021 ; 27 (6): 836-847 Nephropedia Template TP {{tp|p=32793973|t=2021. Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey |pdf=|usr=}}{{32793973}} gab.com Text Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey JO: Inflamm Bowel Dis http://www.kidney.de/pget.php?&tw=1&pmid=32793973 #FOAvip BACKGROUND AND AIMS: Persons with inflammatory bowel disease (IBD) may be particularly vulnerable to COVID-19 either because of their underlying disease or its management. Guidance has been presented on the management of persons with IBD in the time of this pandemic by different groups. We aimed to determine how gastroenterologists around the world were approaching the management of IBD. METHODS: Members of the World Gastroenterology Organization (WGO) IBD Task Force contacted colleagues in countries largely beyond North America and Europe, inviting them to review the WGO website for IBD and COVID-19 introduction, with links to guideline documents, and then to respond to 9 ancillary open-ended management questions. RESULTS: Fifty-two gastroenterologists from 33 countries across 6 continents completed the survey (April 14 to May 16, 2020). They were all adhering for the most part to published guidelines on IBD management in the COVID-19 era. Some differences and reductions in services related to access, and some related to approach within their communities in terms of limiting virus spread. In particular, most gastroenterologists reduced in-person clinics (43 of 52), limited steroid use (47 of 51), limited elective endoscopy (45 of 52), and limited elective surgeries (48 of 51). If a patient was diagnosed with COVID-19, immunomodulatory therapy was mostly held. CONCLUSIONS: In most countries, the COVID-19 pandemic significantly altered the approach to persons with IBD. The few exceptions were mostly based on low burden of COVID-19 in individual communities. Regardless of resources or health care systems, gastroenterologists around the world took a similar approach to the management of IBD. Twit Text FOAVip Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey ????Inflamm Bowel Dis http://www.kidney.de/pget.php?&tw=1&pmid=32793973 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32793973 #FOAvip English Wikipedia <ref>{{Cite pmid|32793973}}</ref> Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey #MMPMID32793973 Bernstein CN; Ng SC; Banerjee R; Steinwurz F; Shen B; Carbonnel F; Hamid S; Sood A; Yamamoto-Furusho JK; Griffiths A; Benchimol EI; Travis S; Lopes S; Rubin DT; Kaplan GG; Armstrong D; Gearry R Inflamm Bowel Dis 2021[May]; 27 (6): 836-847 PMID32793973show ga BACKGROUND AND AIMS: Persons with inflammatory bowel disease (IBD) may be particularly vulnerable to COVID-19 either because of their underlying disease or its management. Guidance has been presented on the management of persons with IBD in the time of this pandemic by different groups. We aimed to determine how gastroenterologists around the world were approaching the management of IBD. METHODS: Members of the World Gastroenterology Organization (WGO) IBD Task Force contacted colleagues in countries largely beyond North America and Europe, inviting them to review the WGO website for IBD and COVID-19 introduction, with links to guideline documents, and then to respond to 9 ancillary open-ended management questions. RESULTS: Fifty-two gastroenterologists from 33 countries across 6 continents completed the survey (April 14 to May 16, 2020). They were all adhering for the most part to published guidelines on IBD management in the COVID-19 era. Some differences and reductions in services related to access, and some related to approach within their communities in terms of limiting virus spread. In particular, most gastroenterologists reduced in-person clinics (43 of 52), limited steroid use (47 of 51), limited elective endoscopy (45 of 52), and limited elective surgeries (48 of 51). If a patient was diagnosed with COVID-19, immunomodulatory therapy was mostly held. CONCLUSIONS: In most countries, the COVID-19 pandemic significantly altered the approach to persons with IBD. The few exceptions were mostly based on low burden of COVID-19 in individual communities. Regardless of resources or health care systems, gastroenterologists around the world took a similar approach to the management of IBD. |*COVID-19[MESH] |Disease Management[MESH] |Gastroenterology/*trends[MESH] |Global Health/*trends[MESH] |Health Care Surveys[MESH] |Humans[MESH] |Inflammatory Bowel Diseases/*therapy[MESH] |Practice Patterns, Physicians'/*trends[MESH]Worldwide Management of Inflammatory Bowel Disease During the COVID-19(epmc).pdf DeepDyve Pubget Overpricing